Cisplatin-carboplatin therapy in extensive non-small cell lung cancer: a cancer and leukemia group B study

This publication has 11 references indexed in Scilit:

• Cisplatin Dose Intensity in Non-Small Cell Lung Cancer: Phase II Results of a Day 1 and Day 8 High-Dose Regimen
  JNCI Journal of the National Cancer Institute, 1989
• Biological properties of ten human ovarian carcinoma cell lines: calibration in vitro against four platinum complexes
  British Journal of Cancer, 1989
• A Comparison of the Toxicity and Efficacy of Cisplatin and Carboplatin in Advanced Ovarian Cancer
  Acta Oncologica, 1989
• Randomized Phase II Evaluation of Iproplatin (CHIP) and Carboplatin (CBDCA) in Lung Cancer
  American Journal of Clinical Oncology, 1988
• Resistance ot cisplatin and analogues: mechanisms and potential clinical implications
  Cancer Chemotherapy and Pharmacology, 1988
• In vitro chemosensitivity of brain tumors to cisplatin and its analogues, iproplatin and carboplatin
  Cancer Chemotherapy and Pharmacology, 1988
• The cytotoxic activity of cisplatin, carboplatin and teniposide alone and combined determined on four human small cell lung cancer cell lines by the clonogenic assay
  European Journal of Cancer and Clinical Oncology, 1988
• High dose carboplatin in the treatment of lung cancer and mesotherlioma: a phase I dose escalation study
  European Journal of Cancer and Clinical Oncology, 1987
• In vitro colony inhibition of carboplatin against stomach and lung cancer cell lines in comparison with cisplatin
  Cancer Chemotherapy and Pharmacology, 1987
• Cell survival in four ovarian carcinoma xenografts following in vitro exposure to melphalan, cisplatin and cis-diammine-1,1-cyclobutane dicarboxylate platinum II (CBDCA, JM8)
  Cancer Chemotherapy and Pharmacology, 1984